Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013)
- PMID: 28435172
- PMCID: PMC5396549
- DOI: 10.1055/s-0035-1557924
Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013)
Abstract
Purpose: Official guideline published and coordinated by the German Society of Gynecology and Obstetrics (DGGG). Hypertensive pregnancy disorders contribute significantly to perinatal as well as maternal morbidity and mortality worldwide. Also in Germany these diseases are a major course for hospitalization during pregnancy, iatrogenic preterm birth and long-term cardiovascular morbidity. Methods: This S1-guideline is the work of an interdisciplinary group of experts from a range of different professions who were commissioned by DGGG to carry out a systematic literature search of positioning injuries. Members of the participating scientific societies develop a consensus in an informal procedure. Afterwards the directorate of the scientific society approves the consensus. Recommendations: This guideline summarizes the state-of-art for classification, risk stratification, diagnostic, treatment of hypertensive pregnancy disorders.
Ziel: Offizielle Leitlinie, publiziert und koordiniert von der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Hypertensive Schwangerschaftserkrankungen verursachen weltweit einen hohen Anteil an der neonatalen und mütterlichen Morbidität und Mortalität. Auch in Deutschland tragen sie wesentlich zu Krankenhauseinweisungen während der Schwangerschaft, iatrogener Frühgeburtlichkeit und kardiovaskulärer Langzeitmorbidität bei. Methoden: Mitglieder der beteiligten Fachgesellschaften entwickeln in einem informellen Prozess einen Konsensus. Anschließend bestätigen die Direktorien der Fachgesellschaften diesen Konsensus. Empfehlungen: In der Leitlinie wird der aktuelle Standard für die Benennung, Früherkennung, Diagnostik, Behandlung und Nachsorge hypertensiver Schwangerschaftserkrankungen gegeben.
Keywords: HELLP syndrome; hypertension; preeclampsia.
Similar articles
-
The Prevention of Positioning Injuries during Gynecologic Operations. Guideline of DGGG (S1-Level, AWMF Registry No. 015/077, February 2015).Geburtshilfe Frauenheilkd. 2015 Aug;75(8):792-807. doi: 10.1055/s-0035-1557776. Geburtshilfe Frauenheilkd. 2015. PMID: 26365999 Free PMC article.
-
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).Geburtshilfe Frauenheilkd. 2015 Oct;75(10):1028-1042. doi: 10.1055/s-0035-1558120. Geburtshilfe Frauenheilkd. 2015. PMID: 26640293 Free PMC article.
-
Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).Geburtshilfe Frauenheilkd. 2015 Nov;75(11):1117-1129. doi: 10.1055/s-0035-1558299. Geburtshilfe Frauenheilkd. 2015. PMID: 26997666 Free PMC article.
-
[The new guideline "Diagnosis and therapy of female urinary incontinence" AWMF register no.: 015-091-important to know].Urologie. 2023 Feb;62(2):141-152. doi: 10.1007/s00120-022-02019-8. Epub 2023 Jan 24. Urologie. 2023. PMID: 36692513 Review. German.
-
[Endometriosis: gynecological diagnosis and treatment : What should pain management specialists know?].Schmerz. 2021 Jun;35(3):172-178. doi: 10.1007/s00482-021-00541-w. Epub 2021 Mar 17. Schmerz. 2021. PMID: 33730222 Review. German.
Cited by
-
The Targeting of Nuclear Factor Kappa B by Drugs Adopted for the Prevention and Treatment of Preeclampsia.Int J Mol Sci. 2022 Mar 7;23(5):2881. doi: 10.3390/ijms23052881. Int J Mol Sci. 2022. PMID: 35270023 Free PMC article. Review.
-
Economic analysis of the use of the Flt-1/PlGF preeclampsia ratio compared to the standard of care in Uruguay.Rev Colomb Obstet Ginecol. 2024 Sep 25;75(3):4148. doi: 10.18597/rcog.4148. Rev Colomb Obstet Ginecol. 2024. PMID: 39530873 Free PMC article. English, Spanish.
-
The Role of Hypertension for Maternal Outcomes of Women with HELLP Syndrome - a Retrospective Study from a Tertiary Obstetric Center.Geburtshilfe Frauenheilkd. 2024 May 17;84(7):635-645. doi: 10.1055/a-2308-9698. eCollection 2024 Jul. Geburtshilfe Frauenheilkd. 2024. PMID: 38993801 Free PMC article.
-
Cardiovascular Risk Reduction in Women Following Hypertensive Disorders of Pregnancy - a Prospective, Randomised, Controlled Interventional Study.Geburtshilfe Frauenheilkd. 2021 Aug;81(8):966-978. doi: 10.1055/a-1345-8733. Epub 2021 Aug 9. Geburtshilfe Frauenheilkd. 2021. PMID: 34393260 Free PMC article.
-
The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.PLoS One. 2022 Mar 11;17(3):e0265080. doi: 10.1371/journal.pone.0265080. eCollection 2022. PLoS One. 2022. PMID: 35275947 Free PMC article.
References
-
- Lo J O, Mission J F, Caughey A B. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol. 2013;25:124–132. - PubMed
-
- Schutte J M, Schuitemaker N W, van Roosmalen J. Dutch Maternal Mortality Committee . Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG. 2008;115:732–736. - PubMed
-
- Center for Maternal and Child Enquiries (CMACE) . Saving Mothersʼ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118 01:1–203. - PubMed
-
- Kuc S, Wortelboer E J, van Rijn B B. et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66:225–239. - PubMed
-
- Akolekar R, Syngelaki A, Poon L. et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources